These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3568629)

  • 1. Formation of covalent complexes between the fourth component of human complement and IgG immune aggregates.
    Alcolea JM; Antón LC; Marqués G; Sánchez-Corral P; Vivanco F
    Complement; 1987; 4(1):21-32. PubMed ID: 3568629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The binding of human complement component C4 to antibody-antigen aggregates.
    Campbell RD; Dodds AW; Porter RR
    Biochem J; 1980 Jul; 189(1):67-80. PubMed ID: 6906229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of a covalent-like interaction between soluble nascent C4b and C4-binding protein.
    Villiers MB; Thielens NM; Reboul A; Colomb MG
    Biochim Biophys Acta; 1982 Jun; 704(2):197-203. PubMed ID: 6980671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C3 binds covalently to the C gamma 3 domain of IgG immune aggregates during complement activation by the alternative pathway.
    Antón LC; Alcolea JM; Sánchez-Corral P; Marqués G; Sánchez A; Vivanco F
    Biochem J; 1989 Feb; 257(3):831-8. PubMed ID: 2784671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.
    Gadd KJ; Reid KB
    Biochem J; 1981 May; 195(2):471-80. PubMed ID: 7316962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway.
    Takata Y; Kinoshita T; Kozono H; Takeda J; Tanaka E; Hong K; Inoue K
    J Exp Med; 1987 Jun; 165(6):1494-507. PubMed ID: 3495629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The binding site of human C4b-binding protein on complement C4 is localized in the alpha'-chain.
    Hessing M; van 'T Veer C; Bouma BN
    J Immunol; 1990 Apr; 144(7):2632-7. PubMed ID: 2319131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgM rheumatoid factor and the inhibition of covalent binding of C4b to IgG in immune complexes.
    Jarvis JN; Lockman JC; Levine RP
    Clin Exp Rheumatol; 1993; 11(2):135-41. PubMed ID: 8508555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ
    J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of covalently linked C3-C3 dimers on IgG immune aggregates.
    Barrio E; Antón LC; Marqués G; Sánchez A; Vivanco F
    Eur J Immunol; 1991 Feb; 21(2):343-9. PubMed ID: 1999223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune precipitates.
    Takata Y; Tamura N; Fujita T
    J Immunol; 1984 May; 132(5):2531-7. PubMed ID: 6232320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.
    Isenman DE; Young JR
    J Immunol; 1984 Jun; 132(6):3019-27. PubMed ID: 6609966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of human C4 to C-reactive protein-pneumococcal C-polysaccharide complexes during activation of the classical complement pathway.
    Volanakis JE; Narkates AJ
    Mol Immunol; 1983 Nov; 20(11):1201-7. PubMed ID: 6558418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C3 binds with similar efficiency to Fab and Fc regions of IgG immune aggregates.
    Antón LC; Ruiz S; Barrio E; Marqués G; Sánchez A; Vivanco F
    Eur J Immunol; 1994 Mar; 24(3):599-604. PubMed ID: 8125130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fluid-phase binding of human C4 and its genetic variants, C4A3 and C4B1, to immunoglobulins.
    Kishore N; Shah D; Skanes VM; Levine RP
    Mol Immunol; 1988 Sep; 25(9):811-9. PubMed ID: 3264881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fourth component of human complement treated with amines or chaotropes or frozen-thawed (C4b-like C4): interaction with C4 binding protein and cleavage by C3b/C4b inactivator.
    von Zabern I; Bloom EL; Chu V; Gigli I
    J Immunol; 1982 Mar; 128(3):1433-8. PubMed ID: 6976993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The covalent interaction of C3 with IgG immune complexes.
    Vivanco F; Muñoz E; Vidarte L; Pastor C
    Mol Immunol; 1999; 36(13-14):843-52. PubMed ID: 10698338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator.
    Fujita T; Gigli I; Nussenzweig V
    J Exp Med; 1978 Oct; 148(4):1044-51. PubMed ID: 702059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and characterisation of the fourth component of bovine complement.
    Groth DM; Wetherall JD; Umotong BA; Sparrow P; Lee IR; Carrick MJ
    Complement; 1987; 4(1):1-11. PubMed ID: 3568627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.